🔎 Trials Near Me

Dachaigh › Myelofibrosis › Washington

Sgrùdaidhean clionaigeach Myelofibrosis ann an Washington

Tha 11 sgrùdaidhean airson Myelofibrosis a’ lorg phàirtichean aig làraichean ann an Washington.

Bailtean ann an Washington

Teacsa sgrùdaidh oifigeil (Beurla)

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

  • University of Washington - Fred Hutchinson Cancer Center, Seattle
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04176198

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

  • Fred Hutch Cancer Research, Seattle
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07357727

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  • University of Washington, Seattle
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07623161

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

  • University of Washington, Seattle
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT05320198

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT04282187

Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT07228624

Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
A’ fastadhÌre 2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 20 Iuch 2026 · NCT04370301

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

  • GSK Investigational Site, Seattle
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Gibl 2026 · NCT06517875

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

  • Fred Hutchinson Cancer Center, Seattle
A’ fastadhÌre 2
Aoisean 18 gu 66 · Gach gnè · Air ùrachadh 17 Màrt 2026 · NCT06859424

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Seattle
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

  • Fred Hutchinson Cancer Centre, Seattle
  • Northwest Medical Specialties, PLLC - Tacoma, Tacoma
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2025 · NCT06479135

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.